Related Experiment Video
Updated: Jun 15, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Evaluation of Rhode Island's Early Geographic COVID-19 Vaccine Prioritization Policy
Taylor M Fortnam1, Laura C Chambers1, Alyssa Bilinski1
1Taylor M. Fortnam, Alyssa Bilinski, Roberta DeVito, and Joseph W. Hogan are with the Department of Biostatistics, and Laura C. Chambers is with the Department of Epidemiology, Brown University School of Public Health, Providence, RI. Lisa Gargano is with the Office of Immunization, and Michelle Wilson is with the Health Equity Institute, Rhode Island Department of Health, Providence.
None:
Objectives. To determine whether geographic prioritization of limited COVID-19 vaccine supply was effective for reducing geographic disparities in case rates. Methods. Rhode Island allocated a portion of the initial COVID-19 vaccine supply to residents of Central Falls, a community already affected by structural policies and inadequate systems that perpetuate health inequities and experiencing disproportionately high COVID-19 morbidity and mortality. The policy was implemented with a culturally and linguistically appropriate community engagement plan and was intended to reduce observed disparities. Using a Bayesian causal analysis with population surveillance data, we evaluated the impact of this prioritization policy on recorded cases over the subsequent 16 weeks. Results. Early geographic prioritization of Central Falls accelerated vaccine uptake, averting an estimated 520 cases (95% confidence interval = 22, 1418) over 16 weeks and reducing cases by approximately 34% during this period (520 averted vs 1519 expected without early prioritization). Conclusions. Early geographic prioritization increased vaccine uptake and reduced cases in Central Falls, thereby reducing geographic disparities. Public Health Implications. Public health institutions should consider geographic prioritization of limited vaccine supply to reduce geographic disparities in case rates. (Am J Public Health. 2024;114(S7):S580-S589. https://doi.org/10.2105/AJPH.2024.307741).
More Related Videos
Related Concept Videos
Vaccinations
Relative Risk

